Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain

Status: Recruiting
Location: See location...
Intervention Type: Dietary supplement
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

The goal of this study is to use pain-specific urine biomarkers to evaluate how daily nutritional supplementation with biomarker guided formulas effect, quality of life and urinary biomarker scores in chronic pain patients. Assessing the effect of biomarker guided supplementation on pain specific biomarkers through changes in urinary biomarker scores may solidify the necessity for identifying deficiencies to create an individualized treatment plan for pain patients. This study aims to evaluate the effect of biomarker-guided supplementation on the three categories of urinary biomarkers using targeted ingredients specifically designed for oxidative stress, inflammation, and nerve health. This study provides subjects with one of three nutritional supplement formulas based on their specific urinary biomarker test results and assesses changes in their urinary biomarker levels and their quality of life as it relates to their pain over a 3-month period.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: t
View:

• Previously submitted a urinary biomarker sample and agreed to be contacted for research.

• Be seeking treatment for chronic pain as defined as symptoms persisting for ≥ 3 months.

• Be able to take oral medication and/or be willing to adhere to the supplement regimen.

Locations
United States
Kentucky
Ethos Research and Development
RECRUITING
Newport
Contact Information
Primary
Brianna Krause, MS
brianna.krause@ethosrd.com
‪(513) 400-3057‬
Time Frame
Start Date: 2024-02-08
Estimated Completion Date: 2025-07-30
Participants
Target number of participants: 75
Treatments
Experimental: Nerve Health
Experimental: Oxidative Stress
Experimental: Inflammation
Related Therapeutic Areas
Sponsors
Leads: Ethos Research & Development

This content was sourced from clinicaltrials.gov